The European AI in antibody identification market is undergoing a notable surge, driven primarily by growing investments in biotechnology and a heightened focus on personalized medicine. Analysts predict substantial advancements in clinical antibody development utilizing artificial intelligence, particularly within fields like oncology and immunolo